Form 4 for AGIO AGIOS PHARMACEUTICALS, INC.
Accepted 2026-03-05 00:00:00 ET · period of report 2026-03-03 · accession 0001439222-26-000046 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-05 | 2026-03-03 | AGIO | Washburn Theodore James Jr. | Principal Accounting Off | S - Sale | $28.88 | -5,272 | 868 | -86% | -$152.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common stock | 2026-03-03 | S | D | 5,272 | $28.88 | 868 | D | — | — |